Advertisement
Screener

STERIS plc (STE) EBITDA

STERIS plc (STE) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $409.6M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA $440.2M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $395.20M*; Operating income $273.20M; Depreciation and amortization $122.00M*.
  • 2025-09-30: Basis Reported; EBITDA $387.50M*; Operating income $265.80M; Depreciation and amortization $121.70M*.

Complete source-backed ebitda history.

Available history
2017-03-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$409.6M(m)(m)(m)27.44%$87.50M$367.10M(m)$28.60M$369.70M$72.50M
2026-03-31Reported$440.2M(m)(m)(m)27.71%(m)(m)(m)(m)(m)(m)
2025-12-31Reported$395.20M*$273.20M$122.00M*(m)(m)$98.70M*$298.20M*(m)$29.50M$352.30M$63.50M
2025-09-30Reported$387.50M*$265.80M$121.70M*(m)(m)$86.50M*$287.80M*(m)$28.20M$349.70M$60.60M
2025-06-30Reported$365.4M(m)(m)(m)26.27%$93.60M$420.00M(m)$26.40M$353.80M$53.90M
2025-03-31Reported$338.4M(m)(m)(m)22.86%(m)(m)(m)(m)(m)(m)
2024-12-31Reported$371.20M*$245.30M$125.90M*(m)(m)$89.20M*$332.80M*(m)$27.40M$335.50M$55.40M
2024-09-30Reported$335.00M*$219.70M$115.30M*(m)(m)$101.90M*$250.80M*(m)$27.00M$329.30M$43.50M
2024-06-30Reported$298.2M(m)(m)(m)23.31%$108.10M$303.70M(m)$25.60M$335.60M$35.30M
2024-03-31Reported$354.71M(m)(m)(m)24.99%(m)(m)(m)(m)(m)(m)
2023-12-31Reported$367.10M*$226.47M$140.63M*(m)(m)$118.94M*$291.24M*$737.70M$25.25M$308.30M$41.00M
2023-09-30Reported$343.81M*$191.55M$152.25M*(m)(m)$83.29M*$146.09M*$691.98M$26.27M$328.43M$35.05M
2023-06-30Reported$335.69M(m)(m)(m)28.37%$66.60M$281.13M$654.38M$24.69M$306.53M$36.20M
2023-03-31Reported$890.52M(m)(m)(m)92.45%(m)(m)(m)(m)(m)(m)
2022-12-31Reported$328.75M*$190.80M$137.95M*(m)(m)$91.82M*$205.58M*$634.24M$25.51M$305.14M$40.53M
2022-09-30Reported-$172.54M*-$306.42M$133.88M*(m)(m)$82.77M*$103.82M*$608.63M$24.93M$323.19M$35.42M
2022-06-30Reported$297.26M(m)(m)(m)25.70%$115.93M$231.75M$577.82M$24.75M$334.63M$26.91M
2022-03-31Reported$377.89M(m)(m)(m)44.51%(m)(m)(m)(m)(m)(m)
2021-12-31Reported$320.54M*$202.93M$117.61M*(m)(m)$81.12M*$244.31M*(m)$24.82M$310.56M$39.31M
2021-09-30Reported$234.54M*$116.50M$118.04M*(m)(m)$76.97M*$171.34M*(m)$18.83M$344.80M$19.98M
2021-06-30Reported$97.95M(m)(m)(m)10.11%$56.40M$97.43M$542.14M$18.19M$393.75M-$7.08M
2021-03-31Reported$203.3M(m)(m)(m)23.27%(m)(m)(m)(m)(m)(m)
2020-12-31Reported$203.85M*$147.03M$56.82M*(m)(m)$53.75M*$205.71M*(m)$16.44M$182.37M$24.84M
2020-09-30Reported$195.68M*$141.26M$54.42M*(m)(m)$43.88M*$161.95M*(m)$16.14M$172.71M$27.78M
2020-06-30Reported$164.77M(m)(m)(m)24.63%$66.86M$134.12M(m)$16.23M$155.17M$19.08M
2020-03-31Reported$208.78M(m)(m)(m)25.37%(m)(m)(m)(m)(m)(m)
2019-12-31Reported$191.94M*$142.39M$49.56M*(m)(m)$55.48M*$131.33M*$442.91M$16.49M$172.93M$29.29M
2019-09-30Reported$176.37M*$126.73M$49.63M*(m)(m)$48.37M*$150.66M*$418.17M$16.25M$175.96M$22.16M
2019-06-30Reported$157.19M(m)(m)(m)22.56%$49.79M$109.34M(m)$15.59M$178.78M$14.63M
2019-03-31Reported$190.7M(m)(m)(m)24.82%(m)(m)(m)(m)(m)(m)
2018-12-31Reported$152.27M*$69.58M$82.69M*(m)(m)$50.69M*$133.88M*$409.24M$15.17M$176.10M$9.33M
2018-09-30Reported$152.70M*$106.58M$46.12M*(m)(m)$34.82M*$125.92M*$394.30M$15.77M$162.31M$17.76M
2018-06-30Reported$141.28M(m)(m)(m)22.12%$27.73M$100.78M(m)$16.22M$158.41M$12.77M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-31Reported$1.59B(m)(m)(m)26.76%$369.00M$1.34B$3.31B$112.90M$1.41B$262.20M
2025-03-31Reported$1.34B(m)(m)(m)24.60%$370.10M$1.15B$3.06B$107.60M$1.33B$184.70M
2024-03-31Reported$1.4B(m)(m)(m)27.27%$360.30M$973.30M$2.92B$103.70M$1.25B$149.50M
2023-03-31Reported$1.34B(m)(m)(m)29.63%$361.97M$756.95M$2.56B$98.48M$1.09B$124.07M
2022-03-31Reported$1.03B(m)(m)(m)24.41%$287.56M$684.81M$2.34B$86.66M$1.32B$82.34M
2021-03-31Reported$767.61M(m)(m)(m)24.70%$239.26M$689.64M$1.76B$66.33M$731.32M$120.66M
2020-03-31Reported$734.28M(m)(m)(m)24.23%$214.52M$590.56M$1.71B$65.55M$716.73M$90.89M
2019-03-31Reported$636.95M(m)(m)(m)22.89%$189.72M$539.50M$1.61B$63.04M$669.94M$64.28M
2018-03-31Reported$578.22M(m)(m)(m)22.07%$165.46M$457.63M(m)$60.78M$631.98M$63.36M
2017-03-31Reported$414.35M(m)(m)(m)15.86%$172.90M$424.09M(m)$59.40M$682.04M$74.02M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B